231 related articles for article (PubMed ID: 26359995)
21. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
[TBL] [Abstract][Full Text] [Related]
22. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study.
Tanaka A; Imanishi T; Kitabata H; Kubo T; Takarada S; Tanimoto T; Kuroi A; Tsujioka H; Ikejima H; Komukai K; Kataiwa H; Okouchi K; Kashiwaghi M; Ishibashi K; Matsumoto H; Takemoto K; Nakamura N; Hirata K; Mizukoshi M; Akasaka T
Eur Heart J; 2009 Jun; 30(11):1348-55. PubMed ID: 19383736
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
[TBL] [Abstract][Full Text] [Related]
24. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
[TBL] [Abstract][Full Text] [Related]
25. Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention.
Chen Y; Wang C; Yang X; Wang L; Sun Z; Liu H; Chen L
Heart Vessels; 2012 May; 27(3):243-9. PubMed ID: 21526420
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Ikenaga H; Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Miura F; Nakama Y; Dai K; Ohtani T; Ohi K; Miki T; Nakamura M; Kishimoto S; Sumimoto Y; Kihara Y
J Cardiol; 2013 Aug; 62(2):71-6. PubMed ID: 23680004
[TBL] [Abstract][Full Text] [Related]
27. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Sen N; Afsar B; Ozcan F; Buyukkaya E; Isleyen A; Akcay AB; Yuzgecer H; Kurt M; Karakas MF; Basar N; Hajro E; Kanbay M
Atherosclerosis; 2013 May; 228(1):203-10. PubMed ID: 23489347
[TBL] [Abstract][Full Text] [Related]
28. The no-reflow phenomenon.
Galiuto L; Rebuzzi AG; Crea F
JACC Cardiovasc Imaging; 2009 Jan; 2(1):85-6. PubMed ID: 19356539
[No Abstract] [Full Text] [Related]
29. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
[TBL] [Abstract][Full Text] [Related]
30. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization.
Niccoli G; Lanza GA; Shaw S; Romagnoli E; Gioia D; Burzotta F; Trani C; Mazzari MA; Mongiardo R; De Vita M; Rebuzzi AG; Lüscher TF; Crea F
Eur Heart J; 2006 Aug; 27(15):1793-8. PubMed ID: 16829540
[TBL] [Abstract][Full Text] [Related]
31. Collateral blood flow can predict myocardial blush grade in primary coronary intervention.
Ilia R; Wolak A; Amit G; Weinstein JM
Catheter Cardiovasc Interv; 2012 Jul; 80(1):67-70. PubMed ID: 21648054
[TBL] [Abstract][Full Text] [Related]
32. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY;
Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142
[TBL] [Abstract][Full Text] [Related]
33. Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Hu T; Wang HC; Wang RT; Lv AL; Luan RH; Li CX; Cheng HX; Xia CH; Tao L
Cardiovasc Ther; 2013 Jun; 31(3):e7-e11. PubMed ID: 22953997
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction.
Tartan Z; Ozer N; Uyarel H; Akgul O; Gul M; Cetin M; Kasikcioglu H; Cam N
Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):441-7. PubMed ID: 17981019
[TBL] [Abstract][Full Text] [Related]
35. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
[TBL] [Abstract][Full Text] [Related]
36. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
[TBL] [Abstract][Full Text] [Related]
37. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
38. Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum.
Sabin P; Koshy AG; Gupta PN; Sanjai PV; Sivaprasad K; Velappan P; Vellikat Velayudhan R
Indian Heart J; 2017 Apr; 69 Suppl 1(Suppl 1):S34-S45. PubMed ID: 28400037
[TBL] [Abstract][Full Text] [Related]
39. Baseline von Willebrand factor plasma levels and no-reflow phenomenon after primary percutaneous coronary intervention for ST segment elevation myocardial infarction.
Sgueglia GA; Niccoli G; Spaziani C; Cosentino N; Russo E; Andreotti F; Lanza GA; Landolfi R; Crea F
Int J Cardiol; 2010 Nov; 145(2):230-232. PubMed ID: 19732980
[TBL] [Abstract][Full Text] [Related]
40. Angiopoietin-like 4 serum levels on admission for acute myocardial infarction are associated with no-reflow.
Bouleti C; Mathivet T; Serfaty JM; Vignolles N; Berland E; Monnot C; Cluzel P; Steg PG; Montalescot G; Germain S
Int J Cardiol; 2015; 187():511-6. PubMed ID: 25863293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
